SCHEMBL14034583

SCHEMBL14034583

CC(=O)Oc1ccc(C(=O)Cl)c(C(=O)Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
MAPT P10636 3/20 0.50
MAPK1 P28482 1/20 0.50
LMNA P02545 3/20 0.48
CYP3A4 P08684 2/20 0.47
ACHE P22303 2/20 0.46
POLB P06746 2/20 0.44
PKM P14618 2/20 0.44
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
GLA P06280 2/20 0.44
GAA P10253 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 1/20 0.43
TTR P02766 1/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ELANE P08246 1/20 0.43
FLT3 P36888 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11330589 0.85 KDM4E (0.57) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL7326050 0.85 KDM4E (0.53) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL14744132 0.85 KDM4E (0.72) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL11703452 0.84 ALDH1A1 (0.40) KDM4EMAPTMAPK1CYP3A4POLB
SCHEMBL312364 0.84 KDM4E (0.51) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL27580216 0.82 KDM4E (0.58) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL11197823 0.80 NPC1 (0.55) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL23668248 0.80 KDM4E (0.47) KDM4EMAPTMAPK1LMNACYP3A4
SCHEMBL9723737 0.79 BACE1 (0.56) KDM4EMAPTMAPK1LMNAPOLB
SCHEMBL4360840 0.78 KDM4E (0.73) KDM4EMAPTMAPK1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275017-A1 AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY MALLINCKRODT LLC 2008-11-06 US disclosed
US-7235685-B2 Aromatic sulfenates for type I phototherapy MALLINCKRODT, INC. (US) 2007-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275017-A1 AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY TYR, SULT1A1, TPST2 KDM4E 2085/4885MAPT 1463/4885MAPK1 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.